OrthoPediatrics (NASDAQ:KIDS) Issues Quarterly Earnings Results

OrthoPediatrics (NASDAQ:KIDS) announced its quarterly earnings data on Tuesday. The company reported ($0.29) EPS for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.04, Zacks reports. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. OrthoPediatrics updated its FY 2025 guidance to EPS.

OrthoPediatrics Stock Performance

KIDS traded down $0.26 on Tuesday, reaching $22.89. The company had a trading volume of 237,721 shares, compared to its average volume of 315,790. The stock has a market cap of $554.30 million, a P/E ratio of -18.61 and a beta of 1.14. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17. OrthoPediatrics has a fifty-two week low of $21.02 and a fifty-two week high of $35.99. The company’s fifty day moving average is $24.38 and its 200 day moving average is $25.97.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on KIDS shares. Truist Financial reduced their price target on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a report on Wednesday, December 18th. Needham & Company LLC reiterated a “buy” rating and set a $42.00 target price on shares of OrthoPediatrics in a research note on Tuesday, January 14th.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.